1. Home
  2. SURG vs CLGN Comparison

SURG vs CLGN Comparison

Compare SURG & CLGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SurgePays Inc.

SURG

SurgePays Inc.

HOLD

Current Price

$0.28

Market Cap

6.4M

ML Signal

HOLD

Logo CollPlant Biotechnologies Ltd

CLGN

CollPlant Biotechnologies Ltd

HOLD

Current Price

$0.34

Market Cap

5.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SURG
CLGN
Founded
2006
2004
Country
United States
Israel
Employees
20
N/A
Industry
Advertising
Industrial Specialties
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.4M
5.2M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
SURG
CLGN
Price
$0.28
$0.34
Analyst Decision
Strong Buy
Buy
Analyst Count
1
2
Target Price
$5.00
$11.00
AVG Volume (30 Days)
5.6M
26.2K
Earning Date
04-14-2026
05-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$136.77
$240.45
Revenue Next Year
N/A
$38.03
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.20
$0.27
52 Week High
$3.14
$3.23

Technical Indicators

Market Signals
Indicator
SURG
CLGN
Relative Strength Index (RSI) 56.03 50.64
Support Level $0.34 $0.30
Resistance Level $0.94 $0.44
Average True Range (ATR) 0.03 0.04
MACD 0.01 0.00
Stochastic Oscillator 72.47 75.34

Price Performance

Historical Comparison
SURG
CLGN

About SURG SurgePays Inc.

Surgepays Inc is a wireless and point of sale technology company focused on serving underserved and value-conscious consumers through a combination of retail distribution and digital acquisition channels. It provides mobile connectivity, financial technology services, and transaction processing solutions through an integrated platform that combines wireless services with point of sale software and retail distribution. It enables in-store and online activation of wireless services, prepaid top-ups, and financial transactions, allowing consumers to access essential services in both local and digital environments. Its segments are wireless services or MVNO Telecommunications, platform services or MVNE Enablement Platform (HERO), and wholesale enablement or Comprehensive Platform Services.

About CLGN CollPlant Biotechnologies Ltd

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives majority revenue, Canada, Europe and Other, and Israel.

Share on Social Networks: